![Stephen K. Burley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen K. Burley
Corporate Officer/Principal bei The Rockefeller University
Aktive Positionen von Stephen K. Burley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Rockefeller University | Corporate Officer/Principal | 01.06.1997 | - |
Karriereverlauf von Stephen K. Burley
Ehemalige bekannte Positionen von Stephen K. Burley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 18.04.2011 |
CASCADIAN THERAPEUTICS INC (USA) | Direktor/Vorstandsmitglied | 09.06.2008 | 04.09.2008 |
Prospect Genomics, Inc.
![]() Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Gründer | 21.12.2009 | - |
Corporate Officer/Principal | - | 21.12.2009 |
Ausbildung von Stephen K. Burley
Harvard University | Doctorate Degree |
University of Oxford | Doctorate Degree |
University of Western Ontario | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Operativ
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 5 |
Health Technology | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Prospect Genomics, Inc.
![]() Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Technology Services |
Cascadian Therapeutics LLC
![]() Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Stephen K. Burley
- Erfahrung